Schneider Electric Launches Global Pharmaceutical Initiative; New Management Team to Help Customers Maximize Productivity of Assets, People
PALATINE, Ill., Nov. 6 /PRNewswire/ -- Electrical industry leader Square D / Schneider Electric has stepped up its support of the pharmaceutical industry with the appointment of an international management team with deep experience in the industry to oversee the company's global pharmaceutical initiatives. Global Marketing Manager Stephen Larson and Global Sales Directors Mark Liston and Ian Job-Smith, who are based in the U.S. and Europe, respectively, have been named to the new posts. They lead an international staff of professionals in delivering a wide variety of product applications and services to the pharmaceutical market, including engineered equipment packages, embedded intelligence devices, software applications and a diverse portfolio of engineering, analytical and diagnostic services. "Creating a team that coordinates our support of the pharmaceutical industry worldwide enables us to put Schneider Electric's considerable muscle to work helping customers maximize the productivity of their assets and people," said Larson, a former Schneider Global Strategic Account Manager. Mark Liston, who served as Global Strategic Account Manager for Merck, coordinated Schneider's support of Merck's domestic and international project activity for the past four years. The relationship between the two companies has influenced a number of Schneider's strategic initiatives in recent years, including asset management, regulatory compliance and the development of intelligent motor control centers. "Our ability to leverage global resources to support customers seamlessly across traditional geographical and cultural boundaries has been a significant benefit to the pharmaceutical industry," Liston said. He pointed to Schneider Electric's new competency center, which provides application and technical resources to pharmaceutical customers, as one example of Schneider's far- ranging initiatives in support of the industry. Among the many products and services now being developed by Schneider in conjunction with pharmaceutical customers are FDA certification services for equipment, electronic validation documentation for 21 CFR Part 11 regulatory compliance and factory automation systems that are both open and secure. Ian Job-Smith, who coordinates Schneider's resources for European-based pharmaceutical companies, also serves as Global Strategic Account Manager for Glaxo-SmithKline. "Our value to pharmaceutical companies is Schneider's ability to consistently provide a compliant solution, no matter where their facilities are located in the world," said Job-Smith. "This consistent global solution helps pharmaceutical customers reduce the cost of constructing and managing their facilities." Job-Smith has been involved with the pharmaceutical industry for the past eight years. In addition to his experience with Glaxo-SmithKline, he has worked with Astra-Zeneca and Novartis. For more information about Schneider Electric solutions for the pharmaceutical industry, call 1-800-392-8781, visit www.SquareD.com or www.schneiderelectric.com or e-mail help@SquareDinfo.com. Schneider Electric, the World's Power and Control Specialist, provides electrical distribution, industrial control and automation products, systems and services to customers in the energy, buildings, industrial and infrastructure markets. With leading international brands such as MERLIN GERIN, MODICON, SQUARE D and TELEMECANIQUE, Schneider Electric's 67,000 employees generated sales of approximately 9.7 billion Euro in 2000 through 9,000 sales outlets in 130 countries. CONTACT: Jeanne Schweder of pricemcnabb, +1-704-916-6173, or firstname.lastname@example.org, for Schneider Electric MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X18115615
SOURCE Schneider Electric
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.